FDA Inspection
Abbvie Operations Singapore Pte LtdAbbvie Operations Singapore Pte Ltd – FDA Inspection, Jun 21, 2024
Record Details
This FDA Inspection record concerns Abbvie Operations Singapore Pte Ltd, with an inspection on June 21, 2024, issued by the Center for Devices and Radiological Health, covering devices.
View Company Profile
ID · cb60b3a5-511e-4d4c-a06f-04bb36763581
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1241925
- FDA center
- Medical Devices & Rad Health
- Project area
- Postmarket Assurance: Devices
FDA Citations
1- 21 CFR 820.20(c)Management review - defined interval, sufficient frequency
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Abbvie Operations Singapore Pte Ltd
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 4, 2026 | Not classified | Office of Inspections and Investigations | |
| May 10, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 5, 2018 | Not classified | Office of Inspections and Investigations | |
| March 9, 2017 | Not classified | Office of Inspections and Investigations |
Other documents for Abbvie Operations Singapore Pte Ltd
- FDA Inspection 1340398 - 2026-09-04
- FDA Inspection 1092479 - 2019-05-10
- FDA Inspection 1077523 - 2018-12-05
- FDA Inspection 1006415 - 2017-03-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.